TransMedics Group is trading at $85.76, down 4.69% in after-hours trading amid weaker broader-market sentiment after closing at $89.98 on September 4, 2026.

  • No new company-specific announcement or earnings release was identified for the after-hours decline.
  • The Nasdaq Composite is down 0.65%, with major indexes lower.
  • Recent second-quarter results, including an EPS miss and reduced margin outlook, remain background concerns.